Connection

Andrea Lombardi to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Andrea Lombardi has written about Antiviral Agents.
Andrea Lombardi
Connection Strength
0.143
Antiviral Agents
  1. Hepatitis C: Is eradication possible? Liver Int. 2019 03; 39(3):416-426.
    View in: PubMed
    Score: 0.074
  2. ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology. 2015; 96(3-4):163-6.
    View in: PubMed
    Score: 0.058
  3. Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med. 2021 08; 15(8):985-992.
    View in: PubMed
    Score: 0.005
  4. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure. J Hepatol. 2019 12; 71(6):1106-1115.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.